A novel therapeutic approach with additional tolvaptan for the patients with hypoalbuminemia or proteinuria.
30 April 2017 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
Momentum Research, Inc., Chapel Hill (United States of America)
51 More presentations in this session
Access the full session
The Event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
30 April 2017
08:30 CET
